Patricia A. Nunes

Patricia A. Nunes

Auto-generated profile, based on publicly available information

Patricia A. Nunes

Molecular Biology and Biotechnology, CCMar, University of Algarve—Campus de Gambelas, 8005-139 Faro, Portugal

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2002 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Sandra TenreiroSandra Tenreiro
Sandra Tenreiro
PNPatrı́cia A Nunes
Patrı́cia A Nunes
CVCristina A Viegas
Cristina A Viegas
MNMónica S Neves
Mónica S Neves
Miguel C. TeixeiraMiguel C. Teixeira
Miguel C. Teixeira
Isabel Sa-CorreiaIsabel Sa-Correia
Isabel Sa-Correia

1 May 2001 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
PNPatrı́cia A. Nunes
Patrı́cia A. Nunes
Sandra TenreiroSandra Tenreiro
Sandra Tenreiro
Isabel Sa-CorreiaIsabel Sa-Correia
Isabel Sa-Correia
As predicted based on structural considerations, we show results indicating that the member of the major facilitator superfamily encoded bySaccharomyces cerevisiaeopen reading frameYIL120wis a multidrug resistance determinant. Yil120wp was implicated in yeast resistance to ketoconazole and quinidine, but not to the stereoisomer quinine; the gene was thus namedQDR1. Qdr1p was proved to alleviate the deleterious effects of quinidine, revealed by the loss of cell viability following sudden exposure of the unadapted yeast population to the drug, and to allow the earlier eventual resumption of exponential growth under quinidine stress. However,QDR1gene expression had no detectable effect on the susceptibility of yeast cells previously adapted to quinidine. Fluorescence microscopy observation of the distribution of the Qdr1-green fluorescent protein fusion protein in living yeast cells indicated that Qdr1p is a plasma membrane protein. We also show experimental evidence indicating that yeast adaptation to growth with quinidine involves the induction of active expulsion of the drug from preloaded cells, despite the fact that this antiarrhythmic and antimalarial quinoline ring-containing drug is not present in the yeast natural environment. However, we were not able to prove that Qdr1p is directly implicated in this export. Results clearly suggest that there are other unidentified quinidine resistance mechanisms that can be used in the absence ofQDR1.

2 December 2003 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
LELaurence M. Elandalloussi
Laurence M. Elandalloussi
RLRicardo B. Leite
Ricardo B. Leite
RARicardo Afonso
Ricardo Afonso
PNPatrı́cia A. Nunes
Patrı́cia A. Nunes
JRJosé A.F. Robledo
José A.F. Robledo
LCLeonor Cancela
Leonor Cancela

19 June 2003 in Biomolecular Engineering
Verified
Journal Article
Closed access
LELaurence M. Elandalloussi
Laurence M. Elandalloussi
RARicardo Afonso
Ricardo Afonso
PNPatricia A. Nunes
Patricia A. Nunes
LCLeonor Cancela
Leonor Cancela